EKF Diagnostics Holdings plc

("EKF" or the "Company")

Long Term Incentive Plan Award

EKF Diagnostics Holdings plc (AIM: EKF), the AIM-listed global diagnostics business, announces that the Board, following the recommendation of the remuneration committee and after consulting its advisers, has today made the following award (the "Award") to Helen Jones (Chief Financial Officer) under the Company's established LTIP that was adopted on 9 September 2025:

The Award has a performance period from the grant date to the third anniversary of the grant date and are subject to the following performance criteria.

The Award shall vest on a sliding scale depending on the total percentage growth of Adjusted EBITDA per share over the Performance Period, as follows:

Jenny Winter, Chair of the Remuneration committee, commented:

"It is important that our newly appointed CFO, Helen, is rewarded such that her performance indicators align with shareholder value creation. I am satisfied that these incentivisation arrangements achieve that objective."

About EKF Diagnostics Holdings plc (www.ekfdiagnostics.com)

EKF is an AIM-listed global diagnostics business focussed on:

·    Point-of-Care analysers in the key areas of Hematology and Diabetes.

·    Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic food and industrial applications.

EKF has headquarters in Penarth (near Cardiff) and operates four manufacturing sites across the US and Germany, selling into over 120 countries world-wide.